The predictive role of TLR4 +3725 G/C polymorphism in community-acquired pneumonia (CAP) severity course among young respondents with cytomegaloviral persistence (CMVP)

K. Chichirelo-Konstantynovych (Vinnytsya, Ukraine), L. Moroz (Vinnytsya, Ukraine), T. Konstantynovych (Vinnytsya, Ukraine)

Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Session: Genetics in chronic pulmonary diseases
Session type: Thematic Poster
Number: 4226
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Chichirelo-Konstantynovych (Vinnytsya, Ukraine), L. Moroz (Vinnytsya, Ukraine), T. Konstantynovych (Vinnytsya, Ukraine). The predictive role of TLR4 +3725 G/C polymorphism in community-acquired pneumonia (CAP) severity course among young respondents with cytomegaloviral persistence (CMVP). 4226

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunity status of community acquired pneumonia (CAP) young patients according concomitant cytomegalovirus persistence (CMVP)
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


Community-acquired pneumonia (CAP) with cytomegaloviral (CMV) persistence at young adults: prevalence and reciprocal burdening
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Community-acquired pneumonia (CAP) in alcoholic patients (AL): differences in aetiology and severity
Source: Eur Respir J 2002; 20: Suppl. 38, 560s
Year: 2002

Prevalence of hyponatremia (HN) in children with community acquired pneumonia (CAP) and its relation to disease severity, outcomes
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021


Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005

The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008


I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Change in the susceptibility pattern of Streptococcus pneumoniae (SP) and risk factors (RF) for antibiotic resistance (AR) in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 546s
Year: 2003

Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011


Association of CRP values with clinico-radiological appearance in adults with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Source: Eur Respir J 2002; 20: 990-995
Year: 2002



The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004

Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

The assessment of prognostic rules in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003

An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


NT pro-NB as a marker of the pneumonia severity in children.
Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others
Year: 2019

C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 545s
Year: 2005

The influence of smoking habit in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003

Detection of liver function in patients with severe community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002

The analysis of efficiency of amoxycillin/clavulanate (AC) usage at inpatients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 2s
Year: 2006